Key Details
Price
$8.05PE Ratio
161.00Annual ROE
1.52%Beta
0.67Events Calendar
Next earnings date:
May 2, 2025Recent quarterly earnings:
Feb 27, 2025Recent annual earnings:
Feb 27, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Oct 23, 2013Analyst ratings
Recent major analysts updates
Sep 16, 24 Cantor Fitzgerald
OverweightSep 9, 24 Cantor Fitzgerald
OverweightSep 6, 24 HC Wainwright & Co.
BuyMar 1, 24 HC Wainwright & Co.
BuyFeb 23, 24 Cantor Fitzgerald
OverweightFeb 22, 24 HC Wainwright & Co.
BuyFeb 16, 24 RBC Capital
OutperformSep 22, 23 HC Wainwright & Co.
BuyAug 7, 23 HC Wainwright& Co.
BuyAug 7, 23 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Aurinia Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Aurinia Pharmaceuticals?
- Does Aurinia Pharmaceuticals pay dividends?
- What sector is Aurinia Pharmaceuticals in?
- What industry is Aurinia Pharmaceuticals in?
- What country is Aurinia Pharmaceuticals based in?
- When did Aurinia Pharmaceuticals go public?
- Is Aurinia Pharmaceuticals in the S&P 500?
- Is Aurinia Pharmaceuticals in the NASDAQ 100?
- Is Aurinia Pharmaceuticals in the Dow Jones?
- When was Aurinia Pharmaceuticals's last earnings report?
- When does Aurinia Pharmaceuticals report earnings?
- Should I buy Aurinia Pharmaceuticals stock now?
What is the ticker symbol for Aurinia Pharmaceuticals?
The ticker symbol for Aurinia Pharmaceuticals is NASDAQ:AUPH
Does Aurinia Pharmaceuticals pay dividends?
No, Aurinia Pharmaceuticals does not pay dividends
What sector is Aurinia Pharmaceuticals in?
Aurinia Pharmaceuticals is in the Healthcare sector
What industry is Aurinia Pharmaceuticals in?
Aurinia Pharmaceuticals is in the Biotechnology industry
What country is Aurinia Pharmaceuticals based in?
Aurinia Pharmaceuticals is headquartered in Canada
When did Aurinia Pharmaceuticals go public?
Aurinia Pharmaceuticals's initial public offering (IPO) was on September 3, 2014
Is Aurinia Pharmaceuticals in the S&P 500?
No, Aurinia Pharmaceuticals is not included in the S&P 500 index
Is Aurinia Pharmaceuticals in the NASDAQ 100?
No, Aurinia Pharmaceuticals is not included in the NASDAQ 100 index
Is Aurinia Pharmaceuticals in the Dow Jones?
No, Aurinia Pharmaceuticals is not included in the Dow Jones index
When was Aurinia Pharmaceuticals's last earnings report?
Aurinia Pharmaceuticals's most recent earnings report was on Feb 27, 2025
When does Aurinia Pharmaceuticals report earnings?
The next expected earnings date for Aurinia Pharmaceuticals is May 2, 2025
Should I buy Aurinia Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions